acetylleucyl-leucyl-norleucinal has been researched along with 1,7-phenanthroline in 1 studies
| Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (1,7-phenanthroline) | Trials (1,7-phenanthroline) | Recent Studies (post-2010) (1,7-phenanthroline) |
|---|---|---|---|---|---|
| 321 | 0 | 53 | 5,049 | 37 | 1,338 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higgins, JA; Kendrick, JS | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and 1,7-phenanthroline
| Article | Year |
|---|---|
Dietary fish oils inhibit early events in the assembly of very low density lipoproteins and target apoB for degradation within the rough endoplasmic reticulum of hamster hepatocytes.
Topics: Animals; Apolipoprotein B-100; Apolipoproteins B; Biomarkers; Cells, Cultured; Cricetinae; Dietary Fats, Unsaturated; Endoplasmic Reticulum, Rough; Fish Oils; Leupeptins; Lipoproteins, VLDL; Liver; Male; Oleic Acid; Phenanthrolines; Plant Oils; Protease Inhibitors | 1999 |